Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?

van Poppelen NM, Drabarek W, Smit KN, Vaarwater J, Brands T, Paridaens D, Kiliç E, de Klein A.

Cancers (Basel). 2019 Aug 17;11(8). pii: E1200. doi: 10.3390/cancers11081200.

2.

Multi-Modality Analysis Improves Survival Prediction in Enucleated Uveal Melanoma Patients.

Drabarek W, Yavuzyigitoglu S, Obulkasim A, van Riet J, Smit KN, van Poppelen NM, Vaarwater J, Brands T, Eussen B, Verdijk RM, Naus NC, Mensink HW, Paridaens D, Boersma E, van de Werken HJG, Kilic E, de Klein A; for the Rotterdam Ocular Melanoma Study Group.

Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3595-3605. doi: 10.1167/iovs.18-24818.

PMID:
31425584
3.

Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.

van Ipenburg JA, de Waard NE, Naus NC, Jager MJ, Paridaens D, Verdijk RM.

Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):2950-2957. doi: 10.1167/iovs.19-27162.

PMID:
31305861
4.

Absence of Intraocular Lymphatic Vessels in Uveal Melanomas with Extrascleral Growth.

van Beek JGM, van den Bosch QCC, Naus N, Paridaens D, de Klein A, Kiliç E, Verdijk RM.

Cancers (Basel). 2019 Feb 15;11(2). pii: E228. doi: 10.3390/cancers11020228.

5.

The treatment outcomes in IgG4-related orbital disease: a systematic review of the literature.

Detiger SE, Karim AF, Verdijk RM, van Hagen PM, van Laar JAM, Paridaens D.

Acta Ophthalmol. 2019 Aug;97(5):451-459. doi: 10.1111/aos.14048. Epub 2019 Feb 7.

PMID:
30734497
6.

Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.

Schrijver B, Kooiman MA, Kasteleijn E, van Holten-Neelen C, Virakul S, Paridaens D, Peeters RP, van Hagen PM, Dalm VASH, Dik WA.

Thyroid. 2019 Mar;29(3):395-404. doi: 10.1089/thy.2018.0544. Epub 2019 Feb 27.

PMID:
30724135
7.

Retrospective study in 608 cases on the rate of surgical site infections after orbital surgery without prophylactic systemic antibiotics.

de Keizer ROB, Kozdras G, Wubbels R, Van den Bosch WA, Paridaens D.

Br J Ophthalmol. 2018 Dec 21. pii: bjophthalmol-2018-312232. doi: 10.1136/bjophthalmol-2018-312232. [Epub ahead of print]

PMID:
30578245
8.

Efficacy of lateral eyelid-block excision with canthoplasty and full-thickness skin grafting in lower eyelid cicatricial ectropion.

Mol I, Paridaens D.

Acta Ophthalmol. 2019 Jun;97(4):e657-e661. doi: 10.1111/aos.13958. Epub 2018 Nov 2.

9.

Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients.

van Beek JGM, Buitendijk GHS, Timman R, Muller K, Luyten GPM, Paridaens D, Naus NC, Kiliç E.

Acta Ophthalmol. 2018 Dec;96(8):841-848. doi: 10.1111/aos.13823. Epub 2018 Oct 3.

PMID:
30284368
10.

Soft contact lens induced blepharoptosis.

Verhoekx JSN, Detiger SE, Muizebelt G, Wubbels RJ, Paridaens D.

Acta Ophthalmol. 2019 Feb;97(1):e141-e142. doi: 10.1111/aos.13863. Epub 2018 Oct 2. No abstract available.

PMID:
30280498
11.

The histological absence of IgG4 positive plasma cells in juvenile xanthogranuloma; comments on 'Systemic juvenile xanthogranuloma: a case report and brief review'.

Detiger SE, Karim AF, van Laar JAM, Paridaens D, Verdijk RM.

Clin Exp Dermatol. 2019 Jan;44(1):91-92. doi: 10.1111/ced.13745. Epub 2018 Sep 21. No abstract available.

PMID:
30240020
12.

The treatment outcomes in IgG4-related disease.

Karim AF, Bansie RD, Rombach SM, Paridaens D, Verdijk RM, van Hagen PM, Van Laar JAM.

Neth J Med. 2018 Aug;76(6):275-285.

13.

The tarsal plate manifestation of IgG4-related disease.

Verhoekx JSN, Karim AF, van Laar JAM, Verdijk RM, Paridaens D.

Int Ophthalmol. 2019 Jul;39(7):1613-1615. doi: 10.1007/s10792-018-0974-3. Epub 2018 Jun 20.

PMID:
29926366
14.

Chromosomal rearrangements in uveal melanoma: Chromothripsis.

van Poppelen NM, Yavuzyigitoglu S, Smit KN, Vaarwater J, Eussen B, Brands T, Paridaens D, Kiliç E, de Klein A.

Genes Chromosomes Cancer. 2018 Sep;57(9):452-458. doi: 10.1002/gcc.4. Epub 2018 Jul 30.

15.

Epibulbar osseous choristoma: a photo essay case report.

Qin V, Verdijk RM, Paridaens D.

Int Ophthalmol. 2019 May;39(5):1137-1139. doi: 10.1007/s10792-018-0914-2. Epub 2018 Mar 27.

PMID:
29589231
16.

Type, severity, management and outcome of ocular and adnexal firework-related injuries: the Rotterdam experience.

Frimmel S, de Faber JT, Wubbels RJ, Kniestedt C, Paridaens D.

Acta Ophthalmol. 2018 Sep;96(6):607-615. doi: 10.1111/aos.13711. Epub 2018 Mar 13.

PMID:
29536639
17.

Reply re: "A Single- Versus Double-Layered Closure Technique in Anophthalmic Surgery".

Verhoekx JSN, Coolman AR, Tse WHW, Paridaens D.

Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):185-186. doi: 10.1097/IOP.0000000000001083. No abstract available.

PMID:
29517604
19.

Excision of nodular basal cell carcinoma involving the lower eyelid tarsal skin using a grey line-splitting, posterior lamella-sparing technique.

Qin V, Paridaens D.

Orbit. 2019 Jun;38(3):205-209. doi: 10.1080/01676830.2018.1441875. Epub 2018 Feb 20.

PMID:
29461902
20.

Graves' orbitopathy: the ongoing search for new treatment strategies.

Dalm VASH, Paridaens D, Peeters RP.

Lancet Diabetes Endocrinol. 2018 Apr;6(4):261-263. doi: 10.1016/S2213-8587(18)30022-6. Epub 2018 Jan 31. No abstract available.

PMID:
29396248

Supplemental Content

Loading ...
Support Center